GlaxoSmithKline Pharmaceuticals board will consider financial results

01 Aug 2012 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 13, 2012, to consider unaudited financial results for the quarter April - June 2012 (Q2) and half year January - June 2012.

The above information is a part of company's filings submitted to BSE.

Glaxosmithkline Phar Share Price

2462.00 6.75 (0.27%)
02-Jan-2026 12:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1728.70
Dr. Reddys Lab 1248.25
Cipla 1507.05
Zydus Lifesciences 916.90
Lupin 2108.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×